EWM
TMO icon

Elevatus Welath Management’s Thermo Fisher Scientific TMO Stock Holding History

Elevatus Welath Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Buy
2,352
+1,351
+135% +$649K 0.29% 74
2026
Q1 		$492K Buy
1,001
+18
+2% +$9.77K 0.26% 72
2025
Q4 		$570K Hold
983
– – 0.16% 85
2025
Q3 		$477K Sell
983
-2
-0.2% -$931 0.14% 76
2025
Q2 		$399K Sell
985
-117
-11% -$48.9K 0.13% 78
2025
Q1 		$548K Buy
1,102
+1
+0.1% +$542 0.31% 49
2024
Q4 		$573K Hold
1,101
– – 0.2% 51
2024
Q3 		$681K Sell
1,101
-116
-10% -$68.7K 0.22% 48
2024
Q2 		$673K Buy
1,217
+1
+0.1% +$573 0.25% 63
2024
Q1 		$707K Buy
1,216
+30
+3% +$16.8K 0.28% 46
2023
Q4 		$629K Buy
1,186
+18
+2% +$8.71K 0.29% 46
2023
Q3 		$591K Buy
1,168
+53
+5% +$28.2K 0.53% 35
2023
Q2 		$582K Buy
+1,115
New +$602K 0.4% 33

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Elevatus Welath Management's TMO Position: Q2 2026 in Review

Elevatus Welath Management increased its Thermo Fisher Scientific (TMO) stake by 135% in Q2 2026, buying an estimated $649K and bringing the position to 2,352 shares worth $1.18M. The position accounts for 0.29% of the portfolio, ranked #74.

Elevatus Welath Management first reported a position in TMO in Q2 2023 and has held it in 13 quarters since. 2,623 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Elevatus Welath Management held 2,352 shares of Thermo Fisher Scientific worth $1.18M as of Q2 2026.
  • Elevatus Welath Management bought 1,351 Thermo Fisher Scientific shares in Q2 2026, an estimated $649K.
  • Thermo Fisher Scientific made up 0.29% of Elevatus Welath Management's portfolio in Q2 2026, its #74 holding.
  • Elevatus Welath Management first reported a position in Thermo Fisher Scientific in Q2 2023 and has held it in 13 quarters since.
  • 2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Elevatus Welath Management's 13F filing for Q2 2026, filed 13 Aug 2026.